Wall Street Thinks Rocket Lab Is a Buy. Here's Why I'm Not So Sure.
Key PointsThe launch of its Neutron rocket was originally expected in 2025 but may slip again until 2027.
Wall Street analysts have taken a bullish stance on Rocket Lab (NASDAQ: RKLB), rating the stock as a buy with an average price target of around $109 per share. However, this is significantly above the current trading price of approximately $64. The company recently reported impressive quarterly earnings, with revenue up by 62% year-over-year, its backlog surpassing $2.3 billion, and an overall positive momentum surrounding Rocket Lab.
Despite these encouraging numbers, the reporter expresses reservations about jumping on the bandwagon. The primary concern is Rocket Lab's inability to achieve profitability, with the situation seemingly worsening rather than improving. In its second-quarter earnings report, the company revealed a sharp increase in total operating expenses, rising from $142 million in the prior year to $274 million by the midpoint of the year.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
